Clinical Trial Update: Tocopherols and Alpha Lipoic Acid Treatment Chronic Kidney Disease (TALAT) [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating tocopherols (vitamin E) and alpha-lipoic acid for chronic kidney disease has completed (TALAT).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease

Drugs mentioned

• Alpha Lipoic Acid (alpha-lipoic acid)
• Alpha-tocopherol (alpha-tocopherol)

Snippet

Sponsor: Vanderbilt University | Conditions: Chronic Kidney Disease | Phase 2 | Status: COMPLETED